US Patent 10130592 Epinephrine formulations
Patent 10130592 was granted and assigned to Par Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 23, 2015
Date of Patent
November 20, 2018
Patent Applicant
Patent Application Number
14863112
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10130592 Epinephrine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
